Skip to main content
Equibles
DMAC logo

DMAC · DiaMedica Therapeutics Inc. · Webcasts, Transcripts & Audio

Track DMAC — free

Use DMAC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DMAC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$8.58 +0.35 (+4.25%)
Russell 2000 member Rebalance outlook locked
Market Cap
$461.60M
Shares
53.93M
Volume · Oct 5 107.47K Avg daily vol (3M) 181.81K

DiaMedica Therapeutics Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for DiaMedica Therapeutics Inc. (DMAC), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →
Investor Update
Investor event
2026-10-23
DiaMedica Therapeutics Inc. (DMAC) October 2026 Investor Update
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-11
DiaMedica Therapeutics Inc. (DMAC) Q2 2026 Earnings Call Transcript
Confident tone Preeclampsia clinical program Fetal growth restriction (FGR) program Remedy-2 acute ischemic stroke trial
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
DiaMedica Therapeutics Inc. (DMAC) Q1 2026 Earnings Call Transcript
Positive tone Preeclampsia clinical program Stroke ReMEDy2 trial Geographic trial expansion
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-31
DiaMedica Therapeutics Inc. (DMAC) Q4 2025 Earnings Call Transcript
Positive tone Preeclampsia program (DM199) Clinical trial enrollment / site expansion Stroke program (ReMEDy2)
Results not yet reported
Audio Transcript Slides 8-K10-K
Investor Update
Investor event
2026-01-21
DiaMedica Therapeutics Inc. (DMAC) January 2026 Investor Update
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q3
2025-11-12
DiaMedica Therapeutics Inc. (DMAC) Q3 2025 Earnings Call Transcript
Confident tone Preeclampsia program and positive interim data U.S. Phase 2 preeclampsia trial planning Interim futility analysis timeline and sample size
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-12
DiaMedica Therapeutics Inc. (DMAC) Q2 2025 Earnings Call Transcript
Confident tone Preeclampsia Phase II interim results U.S. Phase IIb preeclampsia trial planning Preeclampsia program expansion and trial design
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-13
DiaMedica Therapeutics Inc. (DMAC) Q1 2025 Earnings Call Transcript
Confident tone Preeclampsia Phase 2 trial ReMEDy2 stroke program enrollment Clinical / regulatory milestones
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-17
DiaMedica Therapeutics Inc. (DMAC) Q4 2024 Earnings Call Transcript
Confident tone Preeclampsia program progress Clinical trial site activation MeVO/thrombectomy competitive landscape
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-13
DiaMedica Therapeutics Inc. (DMAC) Q3 2024 Earnings Call Transcript
Confident tone ReMEDy2 trial design changes Site activation and enrollment Preeclampsia program
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
DiaMedica Therapeutics Inc. (DMAC) Q2 2024 Earnings Call Transcript
Confident tone Preeclampsia program (DM-199) ReMEDy2 trial enrollment progress R&D expense growth
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-08
DiaMedica Therapeutics Inc. (DMAC) Q1 2024 Earnings Call Transcript
Positive tone ReMEDy2 Trial Site Activation and Enrollment Geographic Expansion of Trial Safety Profile of DM199
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-19
DiaMedica Therapeutics Inc. (DMAC) Q4 2023 Earnings Call Transcript
Positive tone ReMEDy2 trial enrollment progress DM199 clinical profile and stroke market opportunity PRA lawsuit and legal fees
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-13
DiaMedica Therapeutics Inc. (DMAC) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-14
DiaMedica Therapeutics Inc. (DMAC) Q2 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-15
DiaMedica Therapeutics Inc. (DMAC) Q1 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-28
DiaMedica Therapeutics Inc. (DMAC) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-10-26
DiaMedica Therapeutics Inc. (DMAC) Q3 2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-10
DiaMedica Therapeutics Inc. (DMAC) Q2 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
DiaMedica Therapeutics Inc. (DMAC) Q1 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-14
DiaMedica Therapeutics Inc. (DMAC) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-10
DiaMedica Therapeutics Inc. (DMAC) Q3 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-11
DiaMedica Therapeutics Inc. (DMAC) Q2 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
DiaMedica Therapeutics Inc. (DMAC) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-10
DiaMedica Therapeutics Inc. (DMAC) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-04
DiaMedica Therapeutics Inc. (DMAC) Q3 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-05
DiaMedica Therapeutics Inc. (DMAC) Q2 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-13
DiaMedica Therapeutics Inc. (DMAC) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–28 of 28 webcasts
Key facts CIK 1401040 CUSIP 25253X207 13F (30d) 1 filings 1 filers Visit website Investor relations